7731.TWO MARX Biotech Co., Ltd.
- Market cap
- TWD 2.19B
- P/E
- 57.6x
- P/B
- 7.66x
- ROE
- 11.9%
- Dividend yield
- 1.41%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is 7731.TWO undervalued?
Graham numberThe Graham number of MARX Biotech Co., Ltd. cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
MARX Biotech Co., Ltd. fundamental analysis
No fundamental analysis for MARX Biotech Co., Ltd. yet.
MARX Biotech Co., Ltd. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About MARX Biotech Co., Ltd.
MARX Biotech Co., Ltd. engages in the online retail of men's health food and cosmeceutical products. The company was founded in 2015 and is based in New Taipei City, Taiwan.
Full company profileMARX Biotech Co., Ltd. financial statements
MARX Biotech Co., Ltd. annual financial statements (TWD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 97.6M | 111M | 290M | 618M | 636M |
| Gross Profit | 74.8M | 84.2M | 215M | 430M | 395M |
| Operating Income | 15.1M | 898K | -14.3M | -77.4M | -139M |
| EBITDA | 19.0M | 6.97M | -10.5M | -77.2M | 91.0M |
| Net Income | 13.8M | 2.83M | -12.9M | -96.8M | 42.9M |
| EPS | 0.10 | 0.02 | -0.07 | -0.19 | 0.08 |
| Balance Sheet | |||||
| Total Assets | 91.1M | 103M | 395M | 731M | 833M |
| Total Liabilities | 25.5M | 42.5M | 102M | 480M | 473M |
| Shareholders' Equity | 65.6M | 60.7M | 293M | 251M | 359M |
| Cash & Short-term Investments | 16.1M | 27.7M | 153M | 78.2M | 32.8M |
| Total Debt | 2.11M | 13.8M | 1.88M | 277M | - |
| Cash Flow | |||||
| Operating Cash Flow | -16.7M | 11.4M | -14.1M | -107M | -149M |
| Capital Expenditure | 47.0K | 696K | 1.74M | 219M | 14.1M |
| Free Cash Flow | -16.8M | 10.7M | -15.9M | -326M | -163M |
| Ratios | |||||
| ROE | 21.0% | 4.7% | -4.4% | -38.5% | 11.9% |
| ROA | 15.1% | 2.7% | -3.3% | -13.2% | 5.2% |
| Net Profit Margin | 14.1% | 2.6% | -4.5% | -15.7% | 6.8% |
| Debt to Equity | 0.03x | 0.23x | 0.01x | 1.10x | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
MARX Biotech Co., Ltd. dividends
- Dividend yield
- 1.41%
- Forward dividend
- 0.06 TWD
- Payout ratio
- -
- Ex-dividend date
- Aug 28, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | TWD 6.59M | 0.04 | - |
| 2022 | TWD 7.35M | 0.04 | 259.6% |
| 2021 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 2:1 on Jul 11, 2024.
Who owns MARX Biotech Co., Ltd.
Ownership data of MARX Biotech Co., Ltd. is not available yet.
MARX Biotech Co., Ltd. company profile
- Company name
- MARX Biotech Co., Ltd.
- Ticker
- 7731.TWO
- ISIN
- TW0007731002
- Exchange
- Taiwan OTC Exchange
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- Fiscal year end
- December
- Address
- No. 655, Bannan Road, New Taipei City, Taiwan
- Phone
- 886 8 0055 9880
- Website
- marxbiotech.com
About MARX Biotech Co., Ltd.
MARX Biotech Co., Ltd. engages in the online retail of men's health food and cosmeceutical products. The company was founded in 2015 and is based in New Taipei City, Taiwan.
MARX Biotech Co., Ltd. management
2- Yanchao YangGM & Director
- Hao Ping ChenAccounting Supervisor